Taysha Gene Therapies Inc

NASDAQ:TSHA   3:59:50 PM EDT
21.92
+0.02 (+0.11%)
Earnings Announcements

Taysha Gene Therapies Reports Q3 2020 Financial Results

Published: 11/12/2020 21:33 GMT
(TSHA) - Taysha Gene Therapies Reports Third Quarter 2020 Financial Results and Provides Business Update.
Taysha Gene Therapies Inc- Qtrly Loss per Share $1.28.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.